Gene · 6915
Papers1,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative machine learning model for subtype identification and prognostic prediction in lung squamous cell carcinoma. | Discov Oncol | 2025 | 40410522 | PubTator, text mining | PubMed |
| Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration. | Immunity | 2025 | 39938482 | PubTator, text mining | PubMed |
| Identifying potential signatures of immune cells in hepatocellular carcinoma using integrative bioinformatics approaches and machine-learning strategies. | Immunol Res | 2025 | 39904830 | PubTator, text mining | PubMed |
| Identification of hypertension gene expression biomarkers based on the DeepGCFS algorithm. | PLoS One | 2025 | 39854379 | PubTator, text mining | PubMed |
| New antiplatelet approach: inhibiting Pim kinase to reduce constitutive surface expression of thromboxane A2 receptor. | J Thromb Haemost | 2025 | 39798970 | PubTator, text mining | PubMed |
| Constitutive surface expression of the thromboxane A2 receptor is Pim kinase-dependent. | J Thromb Haemost | 2025 | 39798965 | PubTator, text mining | PubMed |
| Effects of exercise on cAMP-mediated platelet inhibition in young women: a pilot study. | Eur J Appl Physiol | 2025 | 39636435 | PubTator, text mining | PubMed |
Integrating network pharmacology, molecular docking and simulation approaches with machine learning reveals the multi-target pharmacological mechanism of Berberis integerrima against diabetic nephropathy. | J Biomol Struct Dyn | 2025 | 38379386 | PubTator, text mining | PubMed |
| [Clinical and genetic associations in patients with non-cardioembolic ischemic stroke]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2024 | 39831357 | PubTator, text mining | PubMed |
| The associations of candidate gene polymorphisms with aspirin resistance in patients with ischemic disease: a meta-analysis. | Hum Genomics | 2024 | 39617913 | PubTator, text mining | PubMed |
| Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells. | Oncotarget | 2024 | 39576661 | PubTator, text mining | PubMed |
| Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats: Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection. | Life Sci | 2024 | 39547431 | PubTator, text mining | PubMed |
| The Impact of TBXA2R Gene Variants on the Risk of Aspirin-Induced Upper Gastrointestinal Bleeding: A Case-Control Study. | Hosp Pharm | 2024 | 39465093 | PubTator, text mining | PubMed |
| Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance. | BMC Med Genomics | 2024 | 38902747 | PubTator, text mining | PubMed |
| TRPV4-Expressing Tissue-Resident Macrophages Regulate the Function of Collecting Lymphatic Vessels via Thromboxane A2 Receptors in Lymphatic Muscle Cells. | bioRxiv | 2024 | 38826322 | PubTator, text mining | PubMed |
| Sodium/Potassium ATPase Alpha 1 Subunit Fine-tunes Platelet GPCR Signaling Function and is Essential for Thrombosis. | bioRxiv | 2024 | 38798556 | PubTator, text mining | PubMed |
| Deciphering the Systemic Impact of Herbal Medicines on Allergic Rhinitis: A Network Pharmacological Approach. | Life (Basel) | 2024 | 38792575 | PubTator, text mining | PubMed |
| Integrating Phenotypic and Chemoproteomic Approaches to Identify Covalent Targets of Dietary Electrophiles in Platelets. | ACS Cent Sci | 2024 | 38435523 | PubTator, text mining | PubMed |
| Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and Thromboxane A2 Receptor. | Int J Mol Sci | 2024 | 38256162 | PubTator, text mining | PubMed |
| Identification of novel F2-isoprostane metabolites by specific UDP-glucuronosyltransferases. | Redox Biol | 2024 | 38211441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6915/papers?page=2